LEIGH CALCOTE: Open Payments
NPI 1508598376 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,862 in 140 payments from 17 companies in 2025. Trend: 2023 $1,652 · 2024 $8,232 · 2025 $4,862
Food & beverage: $2,862Speaker / faculty: $2,000
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $2,533 |
| Axsome Therapeutics, Inc. | 24 | $516 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 27 | $488 |
| Vanda Pharmaceuticals Inc. | 14 | $225 |
| Teva Pharmaceuticals USA, Inc. | 6 | $164 |
| Supernus Pharmaceuticals, Inc. | 7 | $149 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $143 |
| Otsuka America Pharmaceutical, Inc. | 4 | $114 |
| Collegium Pharmaceutical, Inc. | 6 | $114 |
| E.R. Squibb & Sons, L.L.C. | 5 | $106 |
Products named: VRAYLAR, Auvelity, CAPLYTA, FANAPT, REXULTI, AUSTEDO XR, Qelbree, TRINTELLIX.
Industry payments across MS — which companies pay providers there.
